ABC | Volume 112, Nº1, January 2019

Original Article Arq Bras Cardiol. 2019; 112(1):3-10 Tianshu-Chu et al Rapamycin combined with α -cyanoacrylate 1. Blaas I, Heinz K, Wurtinger P, Turkcan A, Tepekoylu C, GrimmM, et al. Vein graft thrombi, a niche for smooth muscle cell colonization - a hypothesis to explain the asymmetry of intimal hyperplasia. J Thromb Haemost. 2016;14(5):1095-104. 2. Hameau DR, Veas PN, Mendez LM, Martinez RG. Focal arterialization and neoatherosclerosis of a saphenous vein graft. Improving our understanding of late graft failures. Arq Bras Cardiol. 2016;107(5):495-6. 3. Sur S, Sugimoto JT, Agrawal DK. Coronary artery bypass graft: why is the saphenous vein prone to intimal hyperplasia? Can J Physiol Pharmacol. 2014;92(7):531-45. 4. Taggart DP, Ben Gal Y, Lees B, Patel N, Webb C, Rehman SM, et al. A randomized trial of external stenting for saphenous vein grafts in coronary artery bypass grafting. Ann Thorac Surg. 2015;99(6):2039-45. 5. Parsonnet V, Lari AA, Shah IH. New stent for support of veins in arterial grafts. Arch Surg. 1963 Oct;87:696-702. 6. Yao J,ZhangY,HuQ,ZengD,HuaF,MengW,etal.Optimizationofpaeonol- loaded poly(butyl-2-cyanoacrylate) nanocapsules by central composite design with response surface methodology together with the antibacterial properties. Eur J Pharm Sci. 2017 Apr 1;101:189-99. 7. Dai L, Gao M, Gu C, Zhang F, Yu Y. Perivenous application of cyanoacrylate tissue sealants reduces intimal and medial thickening of the vein graft and inflammatory responses in a rabbit model of carotid artery bypass grafting. Eur J Cardiothorac Surg. 2016;49(2):675-81. 8. Zou Y, Dietrich H, Hu Y, Metzler B, Wick G, Xu Q. Mouse model of venous bypass graft arteriosclerosis. Am J Pathol. 1998;153(4):1301-10. 9. Jeremy JY, DashwoodMR, Mehta D, Izzat MB, Shukla N, Angelini GD. Nitric oxide, prostacyclin and cyclic nucleotide formation in externally stented porcine vein grafts. Atherosclerosis. 1998;141(2):297-305. 10. Shi Y, O’Brien JE Jr, Mannion JD, Morrison RC, Chung W, Fard A, et al. Remodeling of autologous saphenous vein grafts. The role of perivascular myofibroblasts. Circulation. 1997;95(12):2684-93. 11. Owens CD, Rybicki FJ,WakeN, Schanzer A, Mitsouras D, Gerhard-Herman MD, et al. Early remodeling of lower extremity vein grafts: inflammation influences biomechanical adaptation. J Vasc Surg. 2008;47(6):1235-42. 12. Masuda H, Kawamura K, Nanjo H, Sho E, Komatsu M, Sugiyama T, et al. Ultrastructure of endothelial cells under flow alteration. Microsc Res Tech. 2003;60(1):2-12. 13. Vijayan V, Shukla N, Johnson JL, Gadsdon P, Angelini GD, Smith FC, et al. Long-term reduction of medial and intimal thickening in porcine saphenous vein grafts with a polyglactin biodegradable external sheath. J Vasc Surg. 2004;40(5):1011-9. 14. George SJ, Izzat MB, Gadsdon P, Johnson JL, Yim AP, Wan S, et al. Macro- porosity is necessary for the reduction of neointimal and medial thickening by external stenting of porcine saphenous vein bypass grafts. Atherosclerosis. 2001;155(2):329-36. 15. Owens CD. Adaptive changes in autogenous vein grafts for arterial reconstruction: clinical implications. J Vasc Surg. 2010;51(3):736-46. 16. Angelini GD, Lloyd C, Bush R, Johnson J, Newby AC. An external, oversized, porous polyester stent reduces vein graft neointima formation, cholesterol concentration, and vascular cell adhesion molecule 1 expression in cholesterol-fed pigs. J Thorac Cardiovasc Surg. 2002;124(5):950-6. 17. Kong J, Deng Y, Dong Q, Liu W, Lu Y. Colchicine reduces restenosis after balloon angioplasty treatment for in-stent restenosis. Arch Med Res. 2015;46(2):101-6. 18. Miao LF, Yin YP, Cui YL, Chen LF, Zeng Y, Huang CL, et al. Efficacy and mechanismof localdeliveryofrapamycinandrapamycin-loadedpoly(lactic- co-glycolic) acid nanoparticles on coronary restenosis of injury-stenosis model of minipigs. Zhonghua Yi Xue Za Zhi. 2016;96(1):36-42. 19. GuoM,ZhangY,TianD,WuX,ChenZ,MaL,etal. Inhibitoryeffectoftopical application of 5-fluorouracil on intimal hyperplasia of vein graft. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2009;23(8):940-6. 20. Wang XT, Venkatraman S, Boey F, Loo SC, Tan LP. Effects of controlled- released sirolimus frompolymer matrices on human coronary artery smooth muscle cells. J Biomater Sci Polym Ed. 2007;18(11):1401-14. 21. Taniwaki M, Raber L, Magro M, Kalesan B, Onuma Y, Stefanini GG, et al. Long-term comparison of everolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for percutaneous coronary intervention of saphenous vein grafts. EuroIntervention. 2014;9(12):1432-40. 22. TsujinoM,HirataY,EguchiS,WatanabeT,ChataniF,MarumoF.Nonselective ETA/ETB receptor antagonist blocks proliferation of rat vascular smooth muscle cells after balloon angioplasty. Life Sci. 1995;56(25):PL449-54. 23. Sanmartin M, Fernandez-Ortiz A, Fantidis P, Aragoncillo P, Fernandez- Durango R, Rollin R, et al. Effects of bosentan on neointimal response following coronary angioplasty. Eur J Clin Invest. 2003;33(9):762-8. 24. Aziz O, Rahman MS, Hadjianastassiou VG, Kokotsakis J, Vitali M, Cherian A, et al. Novel applications of Dermabond (2-octyl -cyanoacrylate) in cardiothoracic surgery. Surg Technol Int. 2007 Apr 5;16:46-51. References Author contributions Conception and design of the research: Tianshu-Chu, Congrong-Gao, Zhiwei-zhao; acquisition of data: Tianshu‑Chu, Fei-Ling, Ayu-Sun; analysis and interpretation of the data: Tianshu-Chu, Jing-Cao, Yuanbiao-Zheng, Jianjun Ge; statistical analysis: Tianshu-Chu, Congrong-Gao, Zhiwei-zhao; writing of themanuscript: Tianshu-Chu, Congrong-Gao, Fei-Ling, Ayu-Sun; critical revision of themanuscript for intellectual content: Tianshu- Chu, Congrong-Gao, Zhiwei-zhao, Fei-Ling, Ayu-Sun, JianjunGe. Potential Conflict of Interest No potential conflict of interest relevant to this article was reported. Sources of Funding This study was funded by National Natural Science Foundation of China. Study Association This article is part of the thesis of master submitted by Tianshu-Chu, from Anhui Medical University. Ethics approval and consent to participate This study was approved by the Ethics Committee on Animal Experiments of the Anhui Animal Ehtics Committee under the protocol number ah56743. 9